Reports related to this article:
Project(s): View 4 related projects in PECWeb
Plant(s): View 8 related plants in PECWeb
Released January 03, 2023 | SUGAR LAND
en
Researched by Industrial Info Resources (Sugar Land, Texas)--The Arkansas, Louisiana and Texas (Ark-La-Tex) region has become synonymous with the oil & gas, chemical and other heavy process industries. However, the life science market has begun to gain substantial traction in this region.
As of December 2022, there were 41 life science projects with a total investment value (TIV) of $3.14 billion slated to start construction in 2023. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list of projects.
Notable projects include the $850 million Levit Green Mixed-Use Life Science Campus in Houston, Texas; $60 million Cosmax NBT USA's Garland, Texas, Nutritional plant expansion; $109 million Louisiana State University's Baton Rouge Interdisciplinary Science Building; and $5 million SCA Pharmaceuticals LLC Little Rock, Arkansas, plant expansion. Subscribers can see reports for the Levit Green, Cosmax NBT, Baton Rouge Interdisciplinary Science Building and SCA Pharmaceuticals LLC expansion reports.
This region will continue to see major growth due to lower business costs, incentives and life science-related deficits. Houston has the world-renowned Texas Medical Center, which offers a strong supply of life science talent for the Gulf Coast region.
Also, major firms with a presence in the Ark-La-Tx region, such as Lonza Group (Basel, Switzerland), Fujifilm Diosynth Biotechnologies (College Station, Texas), Dr. Reddy's Laboratories (Hyderabad, India) and Baxter International Incorporated (NYSE:BAX) (Deerfield, Illinois) have ongoing capital needs. Subscribers can click here for the related plant profiles.
IIR's Pharma-Bio database platform currently contains 281 operational plants in this region, with 302 active capital projects worth $10.30 billion. Subscribers can click here for the list of project reports and click here for the related plant profiles.
Subscribers can click here for all project reports referenced in this article and click here for the related plant profiles.
Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking over 200,000 current and future projects worth $17.8 Trillion (USD).
As of December 2022, there were 41 life science projects with a total investment value (TIV) of $3.14 billion slated to start construction in 2023. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list of projects.
Notable projects include the $850 million Levit Green Mixed-Use Life Science Campus in Houston, Texas; $60 million Cosmax NBT USA's Garland, Texas, Nutritional plant expansion; $109 million Louisiana State University's Baton Rouge Interdisciplinary Science Building; and $5 million SCA Pharmaceuticals LLC Little Rock, Arkansas, plant expansion. Subscribers can see reports for the Levit Green, Cosmax NBT, Baton Rouge Interdisciplinary Science Building and SCA Pharmaceuticals LLC expansion reports.
This region will continue to see major growth due to lower business costs, incentives and life science-related deficits. Houston has the world-renowned Texas Medical Center, which offers a strong supply of life science talent for the Gulf Coast region.
Also, major firms with a presence in the Ark-La-Tx region, such as Lonza Group (Basel, Switzerland), Fujifilm Diosynth Biotechnologies (College Station, Texas), Dr. Reddy's Laboratories (Hyderabad, India) and Baxter International Incorporated (NYSE:BAX) (Deerfield, Illinois) have ongoing capital needs. Subscribers can click here for the related plant profiles.
IIR's Pharma-Bio database platform currently contains 281 operational plants in this region, with 302 active capital projects worth $10.30 billion. Subscribers can click here for the list of project reports and click here for the related plant profiles.
Subscribers can click here for all project reports referenced in this article and click here for the related plant profiles.
Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking over 200,000 current and future projects worth $17.8 Trillion (USD).
